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The ostreid herpesvirus (OsHV-1) is one of the major diseases that affect the Pacific
oyster Crassostrea gigas. Selective breeding programs were recently shown to improve
resistance easily to OsHV-1 infections in spat, juvenile, and adult oysters. Nevertheless,
this resistance has never been investigated in larvae, whereas this developmental
stage has crucial importance for the production of commercial hatcheries, as well as
explaining the abundance of spatfall. A first trial tested several viral suspensions at
several concentrations using contaminated water with OsHV-1 in 4- and 10-day-old
larvae that were produced from an unselected broodstock. In follow up on the results,
one viral suspension at a final concentration of 10+6 OsHV-1 DNA copies per L was
used to assess resistance to OsHV-1 infection in C. gigas larvae that were produced
from selected and unselected broodstock. A second trial evaluated OsHV-1 resistance
in larvae from both broodstocks in trials 2a, 2b, and 2c with 4, 10, and 16-day-old
larvae for 7 days, which corresponded to post D larvae, umbo larvae, and eyed larvae,
respectively. The mortality of unchallenged larvae for both stocks were low (<15%) at
day 7 in trials 2a and 2b, whereas it ranged from 48 to 56% in trial 2c. More interestingly,
selected larvae had significantly lower mortality than unselected larvae when exposed to
OsHV-1 in all of the trials. Thus, the mortality was 11 and 49% for the selected larvae at
day 7 post-exposure in trials 2a and 2c, respectively, in comparison with 84 and 97%
for the unselected larvae. Although this difference in mortality was observed at day 5
in trial 2b, it was reduced at day 7, to 86 and 98% for the selected and unselected
larvae, respectively. For the first time in the literature, the difference in mortality or the
delayed onset of mortality between selected and unselected larvae have indicated a
genetic resistance to OsHV-1 infection at the larval stage. Such finding should facilitate
the selective breeding programs focusing on resistance to OsHV-1 infection by reducing
the span of the genetic evaluation, and thus decreasing its cost.
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INTRODUCTION
Global oyster production is largely driven by the Pacific oyster Crassostrea gigas, which represented
97% of production, totaling 4.7 million tons in 2012 and 4 billion US dollars (FAO, 2014). Disease
resistance has been investigated in numerous oyster species, with significant responses to selection
in improving resistance to protozoan, bacteria and viruses such as Haplosporidium nelsoni and
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Perkinsus marinus in Crassostrea virginica (Ford and Haskin,
1987; Ragone Calvo et al., 2003), Marteilia sydneyi and Bonamia
roughleyi in Saccostrea glomerata (Dove et al., 2013), Bonamia
ostreae in Ostrea edulis (Naciri-Graven et al., 1998), Roseovarius
crassostrea in C. virginica (Barber et al., 1998), and Ostreid
herpesvirus type 1 (OsHV-1) in C. gigas (Dégremont et al.,
2015c). Most of these studies have focused on the spat and adult
stages, which could be explained by the cultivation of these stages
by oyster farmers (Dégremont et al., 2015a). However, disease
resistance is poorly investigated in larvae, although disease could
have a significant impact on spatfall in the wild. Similarly,
hatchery production has increased tremendously in recent times,
in particular in C. gigas in France, and larval mortality related
to disease remains a threat to oyster farmers in terms of the
regularity of spat production throughout the whole year.
Pathogens reportedly induce larval mortality in several oyster
species, such as Vibrio coralliilyticus, V. tubiashii, or Vibrio spp
in C. gigas and C. virginica (Estes et al., 2004; Mersni-Achour
et al., 2015; Richards et al., 2015) or V. neptunius and V.
ostreicida in O. edulis (Prado et al., 2005, 2014). With respect to
the ostreid herpes virus, OsHV-1 has been detected since 1991
during mortality-inducing outbreaks in C. gigas larvae, which
were produced in hatcheries in France (Nicolas et al., 1992)
and New Zealand (Hine et al., 1992). More recently, OsHV-1
was also detected in larvae that were produced by hatcheries in
South Korea, but there is no information on the health status
of the larvae (Hwang et al., 2013). The experimental horizontal
transmission of OsHV-1 within C. gigas larvae was successfully
developed under controlled laboratory conditions in 2-day-old
larvae (Le Deuff et al., 1994), 3-day-old larvae (Arzul et al., 2001),
and 7-day-old larvae (Burge and Friedman, 2012). Nevertheless,
all these studies employed larvae that were produced from
unselected broodstock.
In France, higher mortality is now routinely reported in C.
gigas spat and juveniles in relation to OsHV-1, which has been
the case since 2008 (EFSA, 2010, 2015). A specific genotype
called OsHV-1µVar (GenBank accession no. HQ842610) was
ascribed to this mortality (Segarra et al., 2010), which was also
reported in New Zealand (Keeling et al., 2014), Australia (Jenkins
et al., 2013), and several European countries (Peeler et al., 2012;
Roque et al., 2012). Regardless of the OsHV-1 genotype, the
selective breeding program was shown to easily enhance OsHV-
1 resistance in C. gigas spat, juveniles, and adults (Dégremont
et al., 2013, 2015b), and this genetic resistance is higher for older
and larger animals (Dégremont, 2013; Dégremont et al., 2015c).
Nevertheless, this resistance was never previously investigated in
larvae.
This study describes the first investigation of resistance to
OsHV-1 infection in C. gigas larvae from unselected broodstock
and broodstock that was selected for its higher OsHV-1
resistance. Two trials were designed to track the mortality rate in
larvae under experimental infection conditions. The first trial was
set up to test different viral concentrations (based on the number
of OsHV-1 DNA copies) with 4-day-old (trial 1a) and 10-day-old
(trial 1b) unselected larvae. The second trial investigated OsHV-
1 resistance in larvae with selected and unselected broodstocks.
This trial was performed in 4-day-old (trial 2a), 10-day-old (trial
2b), and 16-day-old (trial 2c) larvae corresponding to D or
post D veliger larvae (80–100µm), umbo larvae (110–200µm),
and eyed larvae (250–350µm), respectively. Their mortality was
recorded at days 3, 5, and 7 post-exposure, and the detection of
OsHV-1 DNA was performed by real-time quantitative PCR in
larvae at each date, as well as in seawater at days 0 and 7.
MATERIALS AND METHODS
Broodstocks
The first broodstock consisted of wild adult oysters that were
sampled from the dock at La Tremblade in 2010, and it was used
to produce the unselected larvae. The second broodstock was the
eighth generation of a bi-parental family that had been produced
and selected for its higher resistance to the summer mortality
phenomenon in C. gigas in France (Dégremont et al., 2007,
2010). This family was then reproduced over eight generations
from 2002 to 2010, with ∼30 parents per generation. The family
was subsequently found to have higher resistance to OsHV-1
from 2001 to 2003 (Dégremont, 2003) and to OsHV-1µVar in
the context of the massive mortality that has been occurring in
France since 2008 (Dégremont, 2011; Dégremont et al., 2016).
The selected broodstock was used to produce selected larvae.
Both broodstocks were held until spawning in the conditioning
room of the Ifremer hatchery in La Tremblade, by maintaining
the oysters in a seawater temperature at 20◦C. This water was
UV-treated and enriched with the alga Skeletonema costatum.
Spawn and Larvae
Unselected larvae were produced in April of 2011 for trials 1a
and b, and unselected and selected larvae were produced in June
2011 for trials 2 a, b, and c (Table 1). For each spawn, ripe oysters
were opened and tissue was sampled from the gonad; this sample
was spread on a slide and used to identify the sexes of the oysters
under a microscope. The numbers of parents used for each cross
ranged from 6 to 14 (Table 1). For each parent, the gametes
were collected by stripping the gonad, which were successively
sieved to remove large (>60µm) and small (<20µm) tissue
debris for the eggs and to only remove the large (>60µm)
ones for the sperm. Within the broodstock, eggs from all the
females were mixed and sperm from all the males were added.
After fertilization, embryos were transferred into 150-L tanks
containing filtered and UV-treated seawater at 25◦C, which was
changed three times per week. The larvae were fed daily with the
algae Isochrysis galbana and S. costatum, and they remained in
the hatchery until their evaluation during experimental infection
trials. Density was adjusted from 50 larvae mL−1 at early-stage
larvae to three larvae mL−1 for late-stage larvae, which it is
commonly used by commercial hatcheries. Such densities were
then used for the experimental infections.
Viral Suspensions
Viral suspensions were prepared according to Schikorski et al.
(2011b). In brief, gills and mantles from OsHV-1µVar-infected
oyster spat were dissected and pooled together in a 50mL sterile
tube. All subsequent dilutions were made with 0.22µm-filtered
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TABLE 1 | Summary of experimental OsHV-1 infections in C. gigas larvae.
Trial Broodstock Age (days) Size (µm) Viral suspension Viral concentration Number of tanks
(OsHV-1 DNA copies L−1) per condition
1a Unselected (3♀ × 3♂) 4 80–100 Vir1, Vir 2, Vir3 10+7, 10+8, 10+9, and 0 2
1b 10 110–200 Vir2 10+5, 10+6, 10+7, 10+8, and 0 2
2a Unselected (6♀ × 4♂), selected (10♀ × 4♂) 4 80–100 Vir2 10+6 and 0 3
2b 10 110–200 Vir2 10+6 and 0 3
2c 16 160–320 Vir2 10+6 and 0 3
artificial seawater (ASW). The total mass of the tissues was
weighed, and 10 volumes of 0.22µm ASW were added to the
tube (9mL of seawater per g of tissue). The tissues were then
crushed on ice with an Ultra-Turrax R© mixer (3× 5 s). Following
centrifugation (1000 g, 5min, 4◦C), the supernatant was placed
in a new tube and diluted by adding four volumes of ASW.
Finally, the clarified tissue homogenate was filtered consecutively
through syringe filters at 5, 2, 0.45, and 0.22µm pore sizes under
sterile conditions. Filtered tissue homogenates were stored at 4◦C
until use.
Trial 1: Experimental Infection Trials with
OsHV-1µVar on Unselected Larvae
Before comparing the resistance of the selected and unselected
larvae under OsHV-1 infection in a second trial, a first trial was
set up by using unselected larvae from wild oysters to test several
viral suspensions at several concentrations. The objective of this
trial was to choose one viral suspension at one concentration that
will induce mortality during a span of 1 week in C. gigas larvae.
Trial 1a on 4 Day-Old Larvae at Sizes Ranging from
80 to 100µm
Four-day-old larvae with sizes ranging from 80 to 100µm were
taken from the hatchery and then transferred into a quarantine
room to perform the experimental infection with OsHV-1µvar.
Three viral suspensions (Vir1, Vir2, and Vir3) were tested, each
of which were tested with three final concentrations (10+7, 10+8,
and 10+9 OsHV-1 DNA copies L−1), which corresponded to
a total of nine conditions (Table 1). For each condition, the
larvae (n = 50 larvae mL−1) were placed in two 5 L tanks
in 3 L of 1.0µm-filtered and UV-treated seawater containing
60µL of Flumisol R© at 32% (a quinolone antibiotic) and the viral
suspension. According to the density and the concentration, it
corresponded to 2× 10+2, 2× 10+3, and 2× 10+4 OsHV-1 DNA
copies per larva for the final concentrations 10+7, 10+8, and 10+9
OsHV-1 DNA copies L−1, respectively. Additionally, two control
tanks were tested using the same protocol, but without adding
the viral suspension. Each tank was aerated, and the seawater
temperature was maintained at a 23◦C room temperature. The
larvae were not fed. After 5 days, the seawater in each tank
was transferred into a 5 L beaker and then homogenized, and
260mL was sampled for the mortality estimation. This volume
was then filtered through a 60µm screen to catch dead and live
larvae, which were then transferred into a 15mL tube. Finally, the
tube was gently mixed, and its mortality counts were conducted
under a binocular magnifier using three drops of 200µL each,
which contained the larvae. This step was included to increase the
larval density and better estimate the mortality rates in a small
drop. Larvae that were swimming or showing any movements
(without any visible protists inside the shell) were considered
alive, and the others were dead (empty shells, degradation of
the tissues with brownish and undistinguishable tissues). OsHV-
1 detection was performed on larvae at day 0, before their transfer
in the quarantine room, and on larvae from each tank at day
5. Similarly, seawater from each tank was also screened at day
0 before adding the larvae and after adding the viral suspension
as well as at day 5 at the final counting. All samples were stored
at−20◦C until disease screening.
Trial 1b on 10 Day-Old Larvae with Sizes Ranging
from 110 to 200µm
Similarly, from the unselected larvae that were maintained in the
hatchery, 10-day-old larvae at sizes ranging from 110 to 200µm
were placed in the quarantine room for experimental infection
by OsHV-1µvar. The same protocol was used with the following
modifications. One viral suspension (Vir2) was tested at four
concentrations, namely 10+5, 10+6, 10+7, and 10+8 OsHV-1
DNA copies L−1, corresponding to 2, 20, 200, and 2000 OsHV-
1 DNA copies per larva, respectively. Mortality was estimated 5
and 7 days post-exposure, and the volume that remained after
taking a 260mL sample for mortality counts was returned to the
5 L beaker at day 5. OsHV-1 DNA detection was performed on
the larvae at days 0, 5, and 7 and in the water at days 0 and 7
as described in trial 1a. All samples were stored at −20◦C until
disease screening.
Trial 2: Experimental Infection Trials with
OsHV-1µVar on Unselected and Selected
Larvae
Trial 2a on 4 Day-Old Larvae with Sizes Ranging from
80 to 100µm
Four-day-old unselected larvae at sizes ranging from 80 to
100µm were transferred from the hatchery to the quarantine
room for the experimental infections by OsHV-1µvar as well
as 4-day-old selected larvae. For each group of larvae, six 5 L
tanks containing 3 L each of 1.0µm filtered and UV-treated
seawater containing 60µL of Flumisol R© at 32% were used. Two
treatments were tested with three of the tanks that were used as
control treatments, which is hereafter named the unchallenged
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condition, and for the second treatment, the Vir2 viral suspension
was added to the three other tanks to obtain a final concentration
of 10+6 OsHV-1 DNA copies L−1, which is hereafter named
the challenged condition. Each tank was aerated, the seawater
temperature was maintained at a 23◦C room temperature, and
the larvae were not fed. The density per tank was ∼33 larvae
mL−1, corresponding to a final concentration of 30.3 OsHV-1
DNA copies per larva. The mortality was estimated by following
the same protocol used in trial 1b on days 3, 5, and 7 post-
exposure. OsHV-1 DNA detection was performed on larvae at
days 0, 3, 5, and 7 as well as in the water at days 0 and 7 as
described in trial 1a. All samples were stored at −20◦C until
disease screening.
Trial 2b on 10-Day-Old Larvae with Sizes Ranging
from 110 to 200µm
Similarly, 10-day-old larvae with sizes ranging from 110 to
200µm from the same spawns used in trial 2a (but kept in the
hatchery) were transferred in the quarantine room. The same
protocol used in trial 2a was used, except that the density per tank
was ∼27 larvae mL−1, corresponding to a final concentration of
37.0 OsHV-1 DNA copies per larva. OsHV-1 DNA detection was
performed in the larvae at days 0, 3, 5, and 7 as well as in the
water at days 0 and 7. All samples were stored at −20◦C until
disease screening.
Trial 2c on 16 Day-Old Larvae with Sizes Ranging
from 250 to 350µm
Sixteen-day-old larvae with sizes ranging from 250 to 350µm,
which came from the same spawns used in trial 2a but were kept
in the hatchery, were transferred in the quarantine room. The
same protocol used in trial 2a was used here, except that the
density per tank was ∼3 larvae mL−1 corresponding to a final
concentration of 333.3 OsHV-1 DNA copies per larva. OsHV-1
DNA detection was performed on the larvae at days 0, 3, 5, and 7
as well as on the water at days 0 and 7. All samples were stored at
−20◦C until disease screening.
OsHV-1 DNA Quantification
Total DNA was extracted from the collected larvae as described
in the mortality estimation step (see trial 1a) by using ∼50–
200 larvae per sample. Those larvae were crushed with a piston
pellet and then DNA was extracted with a QIAamp tissue mini
kit according to the manufacturer’s protocol as described in
Schikorski et al. (2011a). Similarly, total DNA was extracted
from the seawater sampled after adding the viral suspension and
before adding the larvae at day 0, as well as at day 5 or 7 post-
exposure, depending of the trial. For each tank, the total DNA
was extracted from 100µL of seawater. A final elution of the
DNA that was extracted from larval samples was performed with
100µL of double-distilled water and 50µL for seawater samples.
The DNA concentration was analyzed spectrophotometrically
(NANODROP R©). A dilution of the larval DNA samples was
performed to reach a final DNA concentration of 4 ngµl−1. DNA
that was extracted from seawater was used without dilution. Each
DNA sample was tested in duplicate qPCR tests.
The detection and quantification of OsHV-1 DNA were
performed for larvae and seawater with the SYBR R© green real-
time PCR protocol described by Pépin et al. (2008) as adapted
for use with DPFor/DPRev primers to target the OsHV-1 DNA
polymerase sequence (ORF 100) (Pépin, 2013). The results were
expressed as the viral DNA copy number per ng of total DNA
and the viral DNA copy number per µL for larvae and seawater,
respectively.
Statistical Analysis
For each count, the mortality was analyzed by binomial logistic
regression throughout the Genmod procedure in SAS R© 9.4
software.
In using 4-day-old unselected larvae for trial 1a, the following
model was used:
Logit (Yij) = log (Yij/(1− Yij))
= µ+ viral suspension i+ concentration j
viral suspension i× concentration j (1)
where Yij is the probability of larval death when exposed to the
ith viral suspension (Vir1, Vir2, and Vir3) at the jth concentration
(10+7, 10+8, and 10+9 OsHV-1 DNA copies L−1), and µ is the
intercept.When a significant interaction was observed, the SLICE
option was used. This approach allowed for a more powerful
analysis than when the model was rerun for each effect because
the degrees of freedom are not reduced (Littell et al., 2002).
For 10-day-old unselected larvae in trial 1b, the model was
reduced to test the OsHV-1 concentration, and statistical analyses
were performed on days 5 and 7 post-exposure.
In trial 2a, 2b, and 2c, mortality was analyzed 7 days post-
exposure by using the following model:
Logit (Yij) = log (Yij/(1− Yij)) = µ+ stock i
+ treatment j+ stock i× treatment j (2)
where Yij is the probability of larval death in the ith
stock (unselected or selected larvae) for the jth treatment
(unchallenged or challenged by OsHV-1), and µ is the intercept.
For trials 2a, 2b, and 2c, and only for the challenged treatment,
the quantification of OsHV-1 DNA was log (Y+ 1) transformed.
For larvae, we analyzed the data through an ANOVA using the
GLM procedure and by using the following model:
Log (Y+ 1ij) = µ+ stock i+ sampling date j (3)
+ stock i× sampling date j (4)
where Yi is the DNA copy number permg of fresh tissue detected
for the ith stock (unselected or selected larvae) at the jth sampling
date (days 3, 5, and 7 post-exposure).
For seawater samples, data were analyzed using the following
model:
Log (Y+ 1ij) = µ+ stock i+ sampling date j+ stock i
× sampling date j (5)
where Yij is the DNA copy number per µl of seawater detected
for the ith stock (unselected or selected larvae) at the jth sampling
date (day 0 and day 7 post-exposure).
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FIGURE 1 | Mortality (% ± SD) of 4 days old unselected oyster larvae at
day 5 post-exposure in trial 1a. Three viral suspensions (Vir1, Vir2, and Vir3)
and three concentrations were used (10+7, 10+8, and 10+9 DNA copies L−1).
RESULTS
TRIAL 1: Experimental Infection Trials with
OsHV-1µVar using Unselected Larvae
Trial 1a on 4-Day-Old Larvae with Sizes Ranging from
80 to 100µm
Mortality was low in unselected 4-day-old control larvae (2.1%),
and ranged from 3 to 99.4% in larvae exposed to OsHV-1 at
day 5 post-exposure (Figure 1). A significant interaction was
found between the viral suspensions (Vir 1, Vir 2, and Vir 3)
and concentrations (10+7, 10+8, and 10+9) at day 5 post exposure
(χ2 = 121.75; p < 0.0001). For Vir 1, the larvae did not exhibit
mortality at 10+7 and 10+8 OsHV-1 DNA copies L−1 but they
had significantly higher mortality at 10+9 OsHV-1 DNA copies
L−1 (χ2 = 279.60; p < 0.0001). For Vir 2 and 3, high mortality
was observed regardless of the Vir2 concentration (χ2 = 0.33;
p = 0.85) and Vir3 concentration (χ2 = 4.93; p = 0.09).
Trial 1b on 10 Day-Old Larvae with Sizes Ranging
from 110 to 200µm
For 10-day-old unselected larvae, the mortality at day 5 post-
exposure remained lower than 3% for the control and those
exposed to a final concentration of 10+5 and 10+6 OsHV-1
DNA copies L−1. Significantly higher mortality (18.1 and 18.6%)
was found for larvae that were exposed to the two higher
concentrations of OsHV-1 DNA (10+7 and 10+8; χ2 = 83.68;
p < 0.0001; Figure 2). Two days later, the control larvae still did
not exhibit mortality (<3%), and the mortality increased from
63.1% at 10+5 to 98.3% at 10+8 (Figure 2) and was significantly
different among the concentrations (χ2 = 119.19; p < 0.0001).
Trial 2: Experimental Infection Trials by
OsHV-1µVar using Unselected and
Selected Larvae
Trial 2a on 4 Day-Old Larvae at Sizes Ranging from
80 to 100µm
For 4-day-old larvae at sizes ranging from 80 to 100µm, the
mortality of the unchallenged larvae was low (<20%) at the end
FIGURE 2 | Mortality (%± SD) of 10 days old unselected oyster larvae
at days 5 and 7 post-exposure in trial 1b. One viral suspension (Vir2) and
four concentrations were used (10+5, 10+6, 10+7, and 10+8 OsHV-1 DNA
copies L−1).
of the trial on day 7 for both the unselected and selected larvae
(Figure 3A). A similar mortality pattern was also observed for
the selected larvae that were exposed to OsHV-1. By contrast, the
unselected larvae that were challenged by OsHV-1 did not exhibit
mortality on day 3, but moderate mortality was observed for one
of the three tanks (36.3%) on day 5 and remained low for the two
others (5.4 and 6.9%). On day 7, mortality was high (83.8%) for
the unselected larvae that were challenged by OsHV-1, ranging
from 63.8 to 94.3%, depending on the tank (Figure 3A).
Statistical analyses revealed a significant interaction between
stocks and treatments (χ2 = 22.73; p < 0.0001; Table 2). At the
stock level, unselected larvae had significantly higher mortality
when exposed toOsHV-1 than those that were not exposed (χ2 =
103.75; p < 0.0001), whereas selected larvae had similar and
low mortality under both conditions (χ2 = 2.82; p < 0.0001).
At the treatment level, unselected larvae had significantly higher
mortality than selected larvae under both treatments, although
the level of significance was much higher under the challenge
condition (Table 2).
Trial 2b on 10-Day-Old Larvae with Sizes Ranging
from 110 to 200µm
Similar to the results obtained for the unchallenged condition in
trial 2a, the 10-day-old unchallenged larvae had low mortality
for both stocks on day 7 (<20%) (Figure 3B). Larvae that were
exposed to OsHV-1 did not exhibit mortality on day 3, and their
mortality was moderate for the selected larvae (25.7%) and high
for the unselected larvae (77.1%) on day 5 (Figure 3B). On day 7,
the mortality was 86.4 and 97.7% for the selected and unselected
larvae, respectively (Figure 3B).
Significant interactions between the stocks and treatments
were evidenced on day 7 (χ2 = 11.80; p = 0.0006; Table 2).
At the stock level, larvae that were exposed to OsHV-1 had
significantly higher mortality than those that were not exposed
in both stocks on day 7 (Table 2). At the treatment level, the
unselected and selected larvae had similar mortality for the
unchallenged condition (χ2 = 0.97; p = 0.32), and the selected
Frontiers in Marine Science | www.frontiersin.org 5 February 2016 | Volume 3 | Article 15
Dégremont et al. OsHV-1 Resistance in Larvae
FIGURE 3 | Mortality (% ± SD) of the unselected and selected larvae on days 3, 5, and 7 post-exposure for the unchallenged and challenged
conditions (10+6 OsHV-1 DNA copies L−1) in trial 2a (A), trial 2b (B), and trial 2c (C) corresponding to 4, 10, and 17-day-old larvae, respectively and
80–100, 110–200, and 160–320µm larvae, respectively.
Frontiers in Marine Science | www.frontiersin.org 6 February 2016 | Volume 3 | Article 15
Dégremont et al. OsHV-1 Resistance in Larvae
TABLE 2 | Logit analysis of the mortality at the end of the trial on day 7 for unchallenged and challenged larvae when using selected OsHV-1-resistant or
unselected broodstocks for 4, 10, and 16 day-old larvae in trials 2a, 2b, and 2c, respectively.
Source df Trial 2a Trial 2b Trial 2c
χ
2 p χ2 p χ2 p
Stock 1 101.96 <0.0001 26.65 <0.0001 26.15 <0.0001
Treatment 1 123.53 <0.0001 563.96 <0.0001 13.97 <0.0001
Stock × Treatment 1 22.73 <0.0001 11.80 0.0006 35.82 <0.0001
SLICE OPTION AT THE STOCK LEVELa
Unselected 1 103.75 <0.0001 112.54 <0.0001 19.37 <0.0001
Selected 1 2.82 0.09 151.57 <0.0001 0.01 0.91
SLICE OPTION AT THE TREATMENT LEVELb
Unchallenged 1 6.49 0.0109 0.97 0.32 1.42 0.23
Challenged 1 117.66 <0.0001 16.56 <0.0001 22.74 <0.0001
aTest for each stock (selected and unselected larvae): the difference in mortality between the larvae challenged with OsHV-1 and the unchallenged larvae.
bTest for each treatment (unchallenged and challenged larvae to OsHV-1): the difference in mortality between the selected and the unselected larvae.
larvae had significantly lowermortality than the unselected larvae
when exposed to OsHV-1 on day 7 (χ2 = 16.56; p < 0.0001;
Table 2).
Trial 2c on 16 Day-Old Larvae with Sizes Ranging
from 250 to 350µm
The 16-day-old larvae exhibited a mortality trend that regularly
increased from day 3 to day 7 for both stocks under the
unchallenged condition, reaching 48.2 and 56.1% for the selected
and unselected larvae, respectively (Figure 3C). A similar
mortality pattern was also observed for the selected larvae that
were exposed to OsHV-1, with a final mortality of 48.9% on day
7. The unselected larvae experienced low mortality (10.7%) on
day 3, which rapidly increased to 81.7% on day 5 and 97.1% on
day 7 (Figure 3C).
Interactions between stocks and treatments in terms of
mortality were again significant at day 7 (χ2 = 35.82; p < 0.0001;
Table 2). At the stock level, selected larvae that were exposed
to OsHV-1 had similar mortality to those that were unexposed
(χ2 = 0.01; p = 0.91). In contrast, unselected larvae exposed
to OsHV-1 had significantly higher mortality than those not
exposed to the virus (χ2 = 19.37; p < 0.0001; Table 2). At the
treatment level, no significant difference in mortality was found
between the unselected larvae and the selected larvae under the
unchallenged condition (χ2 = 1.42; p = 0.23). Conversely,
unselected larvae that were exposed to OsHV-1 had significantly
higher mortality than selected larvae (χ2 = 22.74; p < 0.0001;
Table 2).
OsHV-1 Quantification
Before the experimental infections, OsHV-1 DNA was not
detected in the larvae from all trials.
OsHV-1 Quantification in the Seawater and Larvae in
Trial 1a
For 4-day-old unselected larvae in trial 1a, OsHV-1 DNA was
detected in the seawater at day 0 (<10+1 µL−1) for the control.
Higher amounts were found in seawater and larvae at day 5, but
they were still at a low level (10+3 copies per µL or ng of DNA)
TABLE 3 | Quantification of OsHV-1 DNA in seawater (copies per µL) at
days 0 and 5 post-exposure, and in larvae (copies per ng of DNA) at day 5
in trial 1a.
Viral Viral SeaWater Larvae
concentration suspension
(Copies per L)
Day 0 Day 5 Day 5
10+7 Vir1 0 1.36× 10+4 1.00× 10+2
10+7 Vir2 1.77× 10−1 1.52× 10+5 5.28× 10+6
10+7 Vir3 1.05× 10+1 7.82× 10+4 4.95× 10+6
10+8 Vir1 3.16× 10+0 2.55× 10+4 9.59× 10+4
10+8 Vir2 1.62× 10+1 1.10× 10+4 3.32× 10+6
10+8 Vir3 2.97× 10+2 8.25× 10+4 4.71× 10+6
10+9 Vir1 1.90× 10+1 9.67× 10+4 3.28× 10+6
10+9 Vir2 2.87× 10+2 1.83× 10+4 3.52× 10+6
10+9 Vir3 1.69× 10+3 8.84× 10+3 2.18× 10+6
Control Control 3.91× 10−1 1.75× 10+3 4.73× 10+3
for the control (Table 3). For the other conditions, OsHV-1 DNA
was detected at a low level in the seawater at day 0 (<10+3 µL−1)
and at a much higher level at day 5, ranging from 10+4 to 10+5
DNA copies perµL (Table 3). Similarly, a high amount of OsHV-
1 DNA was detected in the larvae at day 5 for all conditions,
ranging from 10+5 to 10+7 copies per ng of total DNA except
for Vir1 at the lowest concentration tested, for which it was only
10+2 (Table 3).
OsHV-1 Quantification in Seawater and Larvae from
Trial 1b
In assessing 10-day-old larvae for trial 1b, OsHV-1 DNA was
detected in the seawater at day 0 at a low level (<10+2) and
at a higher level at day 7 post-exposure, with concentrations
ranging from 10+2 for the control to 10+4 for the infected
conditions (Table 4). For the larvae, the amount of OsHV-1
DNA remained low in the control at days 5 and 7 (<10+1), and
it reached 10+6 DNA copies per ng of DNA at days 5 and 7
(Table 4).
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TABLE 4 | Quantification of OsHV-1 DNA in seawater (copies per µL) at
days 0 and 5 post-exposure, and in larvae (copies per ng of DNA) at days




Day 0 Day 7 Day 5 Day 7
10+5 1.44× 10+0 1.26× 10+4 6.47× 10+5 3.71× 10+6
10+6 3.98× 10+0 1.82× 10+3 8.32× 10+5 3.21× 10+6
10+7 2.52× 10+0 5.59× 10+2 7.28× 10+5 2.34× 10+5
10+8 1.43× 10+1 3.67× 10+3 2.39× 10+6 8.38× 10+5
Control 2.53× 10+0 6.60× 10+2 2.05× 10+0 1.43× 10+0
OsHV-1 Quantification in the Seawater from Trial 2abc
For 4, 10, and 16-day-old selected larvae and unselected larvae
in trial 2abc, OsHV-1 was not detected in the seawater from
the unchallenged condition at day 0, but it was detected for all
challenged conditions after adding the viral suspension (Vir 2)
containing in average 15 copies of OsHV-1 DNA per µL, and
ranging from 2.94 10−1 to 4.38 10+1 copies of OsHV-1 DNA per
µL, depending of the trial (Table 5).
At day 7, similar copy numbers were observed for trial 2abc,
except that a higher amount of DNA copies were detected for
both stocks under the challenge condition ranging from 6.54 ×
10+1 copies DNA copies per µL for the selected larvae in trial 2c
to 6.11 × 10+3 copies per µL for the selected larvae in trial 2b
(Table 5).
None of the factors (stocks, date of sampling and the
interaction) was significant in trial 2a (p > 0.05). In trial 2b,
only the date of sampling factor was found significant with higher
amount of OsHV-1 DNA at day 7 post-exposure than at day 0
(p < 0.0001). Concerning the trial 2c, only the interaction was
not significant (p > 0.05). Thus, the seawater sampled in tanks
containing the selected larvae had a significant lower amount of
OsHV-1 DNA than the seawater sampled in tanks containing the
unselected larvae (p = 0.0010). Significant higher amount of
OsHV-1 DNA was detected at day 7 than at day 0 (p < 0.0001).
OsHV-1 Quantification in Larvae from Trial 2abc
For 4, 10, and 16-day-old selected larvae and unselected larvae
in trial 2abc, OsHV-1 DNA was detected in the larvae from
the unchallenged condition, but it remained low, at 10+3 DNA
copies per ng of total DNA, throughout the duration of all the
experiments (Figures 4A–C). By contrast, a high level of OsHV-
1 DNA was detected in unselected and selected larvae for the
challenge condition.
Thus, in trial 2a, the OsHV-1 DNA copies per ng of total DNA
ranged from 10+5 to 10+6 for both unselected and selected larvae
at days 3, 5, and 7 (Figure 4A). In a closer look, the OsHV-1
amount reached a peak at day 5 post-exposure for the unselected
larvae, while it was at day 7 for the selected larvae. None of
the factors (stocks, date of sampling and the interaction) was
significant in trial 2a (p > 0.05).
For trial 2b, a high amount of OsHV-1 (10+7) was observed
for both stocks at days 3 and 5, and it dropped significantly to
10+4 at day 7 (p < 0.0001; Figure 4B). The interaction between
stocks and date of sampling was not significant (p = 0.66), and
the amount of OsHV-1 did not significantly differ between the
selected and the unselected larvae (p = 0.06).
For trial 2c, the OsHV-1 amount was again high for the
unselected larvae reaching a peak at day 3 (3.31 × 10+6), and
remained at this level, although it slightly decreased at days 5
and 7 (1 × 10+6 and 9.32 × 10+5, respectively). By contrast,
the amount of OsHV-1 DNA increased regularly from day 3
(10+4) to day 7 (10+5). Interaction and date of sampling were not
significant (p > 0.05) while the amount of OsHV-1 DNA for the
unselected larvae was significantly higher than for selected larvae
(p = 0.0067).
DISCUSSION
The major finding of this study revealed lower mortality
from OsHV-1 in larvae through day 7 post-exposure that
were produced from disease-resistant broodstock in comparison
with larvae that were produced from unselected broodstock
(Figures 3A–C). Consequently, OsHV-1 infection resistance
in C. gigas could be observed at all stages, as previously
demonstrated in spat, juveniles and adults (Dégremont, 2013;
Dégremont et al., 2013). To our knowledge, this is the first report
on a positive response to selection in oyster larvae. A previous
study used an experimental challenge with bacterial pathogens
in larvae from three disease-resistant lines of the eastern oysters
C. virginica (Gomez-Leon et al., 2008). Unfortunately, the line
that was selected for its higher resistance to Roseovarius oyster
disease at the juvenile stage was not tested at the larval stage, and
the two other oyster lines, which were selected for their higher
resistance to P. marinus and/orH. nelsoni,were evaluated against
three bacterial pathogens, namely two Vibrio spp strains and
Roseovarius crassostrea. Nevertheless, the difference in mortality
between lines at the larval stage was observed at 20◦C, suggesting
that resistance to pathogens could be present in the oyster larvae
(Gomez-Leon et al., 2008). Our study strengthens their findings.
We observed high mortality in all larval stages exposed to
OsHV-1µvar from D hinge to eyed larvae. The previous studies
on the horizontal transmission of OsHV-1 in larvae primarily
focused on 2–3-day-old larvae (Le Deuff et al., 1994; Arzul et al.,
2001) or the 7-day-old larvae without any indication about the
sizes of the larvae (Burge and Friedman, 2012). At these ages,
we assumed that the authors had primarily studied D larvae and
small umbo larvae. Consequently, C. gigas larvae are susceptible
to OsHV-1 during their whole planktonic existence. This result
suggests that OsHV-1 is a permanent threat for hatcheries, and
OsHV-1 could be an important regulator of spatfall in C. gigas
in the open environment. Spawning usually occurs during the
summer when the seawater temperature favors the OsHV-1
disease, which is commonly higher than 16◦C in France (Pernet
et al., 2012; Dégremont, 2013). Thus, the absence of significant
C. gigas spatfall from 2009 to 2011 in Arcachon Bay could be
explained by the high mortality caused by OsHV-1 in larvae.
The pathogen hypothesis was unfortunately not investigated, but
others were tested, such as the spatial distribution of broodstocks,
their trophic competition, the presence of pollutants or a decrease
or change in trophic resources (Bernard et al., 2014). However,
some assays for OsHV-1 detection were performed on frozen
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FIGURE 4 | OsHV-1 DNA copies per ng of total DNA (% + SD) in unselected and selected larvae on days 3, 5, and 7 post-exposure for the
unchallenged and challenged conditions (0 and 10+6 OsHV-1 DNA copies L−1, respectively) in trial 2a (A), trial 2b (B), and trial 2c (C) corresponding to
4, 10, and 17 day-old larvae, respectively and 80–100, 110–200, and 160–320µm larvae, respectively.
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TABLE 5 | Quantification of OsHV-1 DNA in seawater (copies per µL) for the unchallenged and challenged conditions in trial 2a, trial 2b, and trial 2c.
Trial Age (days) Size (µm) Stock Unchallenged Challenged
Day 0 Day 7 Day 0 Day 7
2a 4 80–100 Unselected Not detected Not detected 2.94× 10−1 3.16× 10+2
Selected Not detected Not detected 1.23× 10+1 2.41× 10+2
2b 10 110–200 Unselected Not detected Not detected 1.97× 10+1 2.94× 10+3
Selected Not detected Not detected 4.38× 10+1 6.11× 10+3
2c 17 160–320 Unselected Not detected Not detected 1.37× 10+1 4.58× 10+2
Selected Not detected Not detected 1.40× 10+0 6.54× 10+1
samples from an oyster larval abundance survey in Marennes
Oléron Bay. These samples were collected during the spawning
season in 2009, 2010, and 2011, and they revealed a positive
signal for viral DNA in the larvae (unpublished data). It would be
interesting to extend studies to determine whether exposed larvae
are able to settle and become spat.
For the larvae that were experimentally infected by OsHV-1,
the quantity of the virus found in seawater increased significantly
in all trials from days 0 to days 5 and 7 (Tables 3–5). These
results suggest that OsHV-1 replicated in the larvae, which were
then released in the seawater. This finding is consistent with the
experimental OsHV-1 challenge in C. gigas spat, for which viral
DNA was not detected at time 0, but it increased to 10+3 copies
per µL by 5 days later (Schikorski et al., 2011a). In contrast to the
results of Schikorski’s study, OsHV-1 DNA was also detected in
seawater at day 0 and days 5 or 7, and in larvae at days 5 or 7
for the unchallenged condition, but the viral copy level was low
(<10+3). Despite the presence of viral DNA, no mortality was
reported in unchallenged larvae in all trials, excepted for in trial
2c, which will be explained below, suggesting that this is just a
trace of viral DNA and not virulent particles. Its detection could
be explained by the seawater that was pumped into theMarennes-
Oléron Bay, where mortality related to OsHV-1 was reported
during this period (Dégremont et al., 2016). Thus, filtration
at 1.0µm and UV-treated seawater likely removed most viral
particles, and the OsHV-1 DNA we detected was likely inactive
viral particles or degraded DNA. This finding is consistent with a
hypothesis suggesting that OsHV-1 may be carried on abioseston
particles and organic matter and that the removal of the putative
particulate vector of OsHV-1 from seawater using filtration at
5µm enabled C. gigas spat to survive in spite of the presence of
OsHV-1µVar in the water supply (Whittington et al., 2015).
For 4-day-old unselected larvae (trial 2a), the unselected and
selected larvae did not suffer frommortality at day 3 (Figure 3A).
In fact, the amount of OsHV-1 detected in the larvae increased
from none at day 0 to 10+5 copies per ng of DNA at day
3(Figure 4A), suggesting the active multiplication of the virus
in both stocks. This fast proliferation in the larvae was already
reported during the experimental infection of larvae by OsHV-
1 (Le Deuff et al., 1994; Burge and Friedman, 2012). Although
the amount of OsHV-1 was slightly higher at day 5 for both
stocks, unselected larvae had 8-fold times more OsHV-1 DNA
detected than selected larvae, and only unselected larvae started
dying. This is in agreement with finding obtained in OsHV-1-
resistant and unselected in C. gigas spat tested in field condition
(Dégremont, 2011). A high-mortality outbreak related to OsHV-
1 was observed between days 5 and 7 post-exposure, again only
for the unselected larvae. Although the OsHV-1 amount slightly
decreased in unselected larvae from days 5 to 7, it was still
increasing in selected larvae during this period, which still did not
exhibit significant mortality (Figures 3A, 4A). Dégremont (2011)
reported that the mortality peak immediately followed the viral
load peak in C. gigas spat, suggesting that selected larvae could
have experienced mortality if the trial had lasted longer. At this
age, selected larvae seemed to be resistant to OsHV-1 infection,
or the onset of mortality related to OsHV-1 took longer to appear,
underlying the genetic resistance of C. gigas in small larvae.
For 10-day-old larvae (trial 2b), mortality came earlier,
between days 3 and 5 post-exposure for unselected larvae, which
was concomitant with the large amount of OsHV-1 DNA on
both dates (Figures 3B, 4B). Though mortality was high for
the unselected larvae at day 5 (77.1%), this mortality level was
only observed 2 days later for the selected larvae. Thus, for the
first time, we demonstrated that selected larvae can suffer high
mortality from OsHV-1. This finding also revealed that the onset
of mortality was delayed for the selected larvae, confirming their
higher genetic resistance in comparison with unselected larvae.
Even if the selected larvae experienced mortality from OsHV-
1, this finding is consistent with the results found under field
conditions. Indeed, resistant stocks always experienced mortality
related to OsHV-1 infection in spat and juveniles, sometimes
reaching 50%, whereas unselected stocks experienced higher
mortality, usually reaching 90% (Dégremont, 2013; Dégremont
et al., 2015c). One hypothesis to explain the higher mortality
in larvae than in spat for the selected stock could be related
to their younger age and smaller size. OsHV-1 resistance was
shown to increase with age and size, and older animals are
generally less affected (Pernet et al., 2012; Dégremont, 2013).
Another hypothesis could be related to the development of the
immune system. Tirape et al. (2007) showed that the immune
system develops gradually throughout the life of the animal, and
the animal is then able to respond to stress. In addition, the
expression of certain genes related to the immune profile was
variable depending on the developmental stage of the larvae.
The last hypothesis relies on the experimental protocol itself.
Our experimental infection was performed in flasks without
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renewing the seawater and without adding food contrasting with
the study conducted by Burge and Friedman (2012) where those
were renewed or fed daily. These conditions could have favored
the disease, given that OsHV-1 mortality decreased with water
renewal in C. gigas spat (Petton et al., 2015) and that energy
reserves were diminished in infected oysters (Tamayo et al.,
2014). To conclude with trial 2b, the significant decrease in the
amount of OsHV-1 from 10+7 at day 5 to 10+4 at day 7 may be
the consequence of the decreased replication of OsHV-1 because
of the lack of live larvae between days 5 and 7 for both stocks
(Figure 4C). This is in agreement with the findings obtained by
Burge and Friedman (2012).
For the first time, 16-day-old larvae were evaluated for
OsHV-1 resistance during 2c. These larvae exhibited moderate
mortality, reaching 50% at day 7 for selected or unselected larvae
under unchallenged conditions as well as for selected larvae
under the challenged condition (Figure 3C). According to the
quantification of OsHV-1, those findings were not related to
OsHV-1. To explain this mortality, we hypothesized that in
addition to the absence of feeding, the larvae were at a sensitive
step of their lives, given that they were eyed larvae, and near
metamorphosis at that. Nevertheless, when exposed to OsHV-1,
unselected larvae exhibited higher mortality than selected larvae,
which was related to OsHV-1 according to the OsHV-1 DNA
detected at days 3, 5, and 7. At this stage, unselected larvae had
a significant larger amount of OsHV-1 DNA than selected larvae
(Figure 4C), strongly supporting the idea that genetic resistance
was present at this stage of development.
In following up with our findings, the next step is to study
the molecular mechanisms and protein expression in unselected
and selected larvae before, during and after an experimental
infection with the OsHV-1 virus. It also appears that the
larval model would be a powerful approach to understanding
genetic resistance to OsHV-1 better as well as facilitating a
selective breeding program. Indeed, the family that showed
higher resistance to OsHV-1 infection could be identified a
couple days after spawning, allowing it to reduce the span of the
genetic evaluation, and thus decreasing the cost of the breeding
program. Finally, monitoring oyster larvae through settlement
to juveniles when exposed to OsHV-1 should also useful to
better understand the abundance of spatfall, which is of great
importance for oyster farmers.
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